论文部分内容阅读
脑梗塞的治疗目前临床用药品种繁多,在抗凝溶栓方面我们采用空军航空医学研究所生产的消栓灵注射液取得了显著的治疗效果。现将我院1990年4月～1993年5月收治的210例脑梗塞疗效观察报告如下。 1 资料和方法 1.1 临床资料 全部病例均系我院患者,发病4小时～8年不等,均符合1986年中华医学会第二次全国脑血管疾病学术会议上通过的诊断标准,并经头颅CT证实。治疗组210例,男150例,女60例;年龄34～76岁,平均62岁。大面积脑梗塞56例,复发性48例,脑干梗塞11例,小脑梗塞17例,腔隙性梗塞78例,合并高血压者102例,糖尿病30例,冠心病76例。对照组200例,男140例,女60例;平均61.7岁。大面积脑梗塞43例,复发性32例,脑干梗塞9例,小脑梗塞23例,腔隙性脑梗塞93例,合并高血压者107例,糖尿病28例,冠
The treatment of cerebral infarction Currently a wide range of clinical medication, anticoagulant thrombolytic aspects we use the Air Force Institute of Aviation Medical Xiaoxiling injection achieved significant therapeutic effect. Now our hospital from April 1990 to May 1993 treated 210 cases of cerebral infarction efficacy report is as follows. 1 Materials and Methods 1.1 Clinical data All cases were patients in our hospital, the onset of 4 hours to 8 years, are in line with the 1986 Chinese Medical Association second national conference on cerebrovascular disease by the diagnostic criteria adopted by the head CT Confirmed. Treatment group 210 cases, 150 males and 60 females; aged 34 to 76 years, mean 62 years. 56 cases of large area cerebral infarction, recurrent 48 cases, 11 cases of cerebral infarction, cerebellar infarction in 17 cases, lacunar infarction in 78 cases, 102 cases of hypertension, 30 cases of diabetes, 76 cases of coronary heart disease. Control group of 200 cases, 140 males and 60 females; average 61.7 years. Large area cerebral infarction in 43 cases, recurrent in 32 cases, brain stem infarction in 9 cases, 23 cases of cerebellar infarction, lacunar infarction in 93 cases, 107 cases of hypertension, 28 cases of diabetes, the crown